Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ADELAIDE, South Australia, April 23, 2013 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) announced today that it has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies.
Help employers find you! Check out all the jobs and post your resume.
